![]() |
市场调查报告书
商品编码
1819897
2025-2033 年消融设备市场报告(按设备技术、应用、最终用户和地区)Ablation Devices Market Report by Device Technology, Application, End User, and Region 2025-2033 |
2024年,全球消融设备市场规模达65亿美元。展望未来, IMARC Group预计到2033年,市场规模将达到155亿美元,2025-2033年期间的复合年增长率(CAGR)为9.7%。危及生命的疾病日益流行,电生理学在切除异常组织方面的广泛应用,以及配备机器人导航系统的下一代消融设备的开发,是推动市场发展的一些关键因素。
消融器械是用于各种医疗程序的医疗器械或工具,用于切除或破坏组织,通常用于治疗或控制某些疾病。这些器械的工作原理是将热能、冷能或射频等能量输送到目标组织,从而切除或改变组织。消融手术创伤小,通常比传统手术更受欢迎,因为它们通常疼痛更少、恢復时间更短,并能降低併发症风险。
市场正经历由几个关键因素驱动的成长,包括癌症、心房颤动和慢性静脉功能不全 (CVI) 等危及生命的疾病的盛行率不断上升。疾病发生率的上升凸显了对有效消融手术的需求。此外,大众对微创消融技术可用性的认识不断提高,这推动了市场扩张。这些手术具有许多优势,包括减轻疼痛、最小疤痕、减少不适和加快患者康復时间。此外,透过移除异常组织来解决心律不整和心律不整的电生理手术的广泛采用,也对市场成长做出了重大贡献。此外,製造商还在响应不断变化的医疗需求,透过创建非热、非肿胀和非硬化的静脉内消融设备来有效治疗浅静脉逆流。
危及生命的疾病日益流行
癌症仍然是全球主要死因之一,近年来发病率不断上升。消融手术,尤其是在肿瘤学领域,作为外科手术的微创替代方案,已逐渐受到重视。它们被用来破坏肝臟、肾臟和肺部等各种器官的癌症组织。此外,静脉内静脉血栓形成 (CVI) 是指腿部静脉无法充分将血液回流至心臟,导致疼痛、肿胀和皮肤改变的疾病。目前,静脉内消融手术通常透过关闭功能障碍的静脉来治疗 CVI。 CVI 发病率的上升通常与生活方式和老化有关,这推动了对静脉治疗消融设备的需求。
电生理学的广泛应用
电生理学是心臟病学的一个分支,研究心臟的电活动。由于其在诊断和治疗各种心律不整(包括心房颤动)方面的有效性,该学科的应用范围正在迅速扩大。电生理导引的消融手术需要精确定位并消除心臟中异常电讯号的来源。这种方法已成为许多心律不整的标准治疗方法,为患者缓解症状、改善生活品质提供了机会。此外,随着医疗保健专业人员日益认识到电生理引导消融的益处,其应用也日益广泛,从而导致对相关消融器械和设备的需求不断增长。
下一代消融设备与机器人导航系统的集成
消融设备领域的技术进步是重要的驱动力。下一代消融设备整合了机器人导航系统,可提高精准度、准确性和手术效果。机器人辅助消融可以实现更可控、更精准的组织消融,从而降低併发症风险并改善患者预后。这些机器人系统提供治疗区域的即时成像和映射,使医护人员能够更自信地导航复杂的解剖结构。因此,这些先进消融设备的采用率正在上升,尤其是在寻求提供一流治疗方案的医疗机构中。提高病患安全性和手术成功率的前景进一步刺激了对这些设备的需求。
The global ablation devices market size reached USD 6.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.5 Billion by 2033, exhibiting a growth rate (CAGR) of 9.7% during 2025-2033. The increasing prevalence of life-threatening diseases, the widespread adoption of electrophysiology to remove abnormal tissues, and the development of next-generation ablation devices with robotic navigation systems represent some of the key factors driving the market.
Ablation devices are medical instruments or tools used in various medical procedures to remove or destroy tissue, typically with the goal of treating or managing certain medical conditions. These devices work by delivering energy, such as heat, cold, or radiofrequency, to the targeted tissue, causing its removal or alteration. Ablation procedures are minimally invasive and are often preferred over traditional surgical methods because they typically result in less pain, shorter recovery times, and reduced risk of complications.
The market is experiencing growth driven by several key factors, including the increasing prevalence of life-threatening diseases such as cancer, atrial fibrillation, and chronic venous insufficiency (CVI). This rise in disease incidence underscores the demand for effective ablation procedures. Furthermore, the growing awareness among the public about the availability of minimally invasive ablation techniques is propelling market expansion. These procedures offer numerous advantages, including reduced pain, minimal scarring, decreased discomfort, and quicker patient recovery times. Additionally, the widespread adoption of electrophysiology procedures to address irregular heart rhythms and cardiac arrhythmia by removing abnormal tissues is contributing significantly to market growth. Besides, manufacturers are also responding to evolving medical needs by creating non-thermal, non-tumescent, and non-sclerosant endovenous ablation devices tailored for the effective treatment of superficial vein reflux.
Increasing prevalence of life-threatening diseases
Cancer remains one of the leading causes of death worldwide, with a rising incidence in recent years. Ablation procedures, particularly in oncology, have gained prominence as minimally invasive alternatives to surgery. They are employed to destroy cancerous tissues in various organs, such as the liver, kidney, and lung. Moreover, CVI is a condition where veins in the legs fail to adequately return blood to the heart, leading to pain, swelling, and skin changes. Endovenous ablation procedures are now commonly used to treat CVI by closing off malfunctioning veins. The rising incidence of CVI, often associated with lifestyle factors and aging, has driven the demand for ablation devices designed for venous treatments.
Widespread adoption of electrophysiology
Electrophysiology is a branch of cardiology that deals with the electrical activity of the heart. It has witnessed a surge in adoption due to its effectiveness in diagnosing and treating various cardiac arrhythmias, including atrial fibrillation. Electrophysiology-guided ablation procedures involve precisely locating and eliminating the source of abnormal electrical signals in the heart. This approach has become the standard of care for many heart rhythm disorders, offering patients a chance for symptom relief and improved quality of life. Moreover, with healthcare professionals increasingly recognizing the benefits of electrophysiology-guided ablation, its adoption has become widespread, leading to a growing demand for related ablation devices and equipment.
Integration of next-generation ablation devices with robotic navigation systems
The advancement of technology in the field of ablation devices is a significant driving force. Next-generation ablation devices incorporate robotic navigation systems, which enhance precision, accuracy, and procedural outcomes. Robotic-assisted ablation allows for more controlled and targeted tissue ablation, reducing the risk of complications and improving patient outcomes. These robotic systems provide real-time imaging and mapping of the treatment area, enabling healthcare providers to navigate complex anatomical structures with greater confidence. As a result, the adoption of these advanced ablation devices is on the rise, particularly among healthcare facilities looking to offer state-of-the-art treatment options. The promise of improved patient safety and procedural success rates further fuels the demand for these devices.
Radiofrequency devices represent the most used device technology
RF ablation has demonstrated effectiveness across a wide range of medical applications. It is used to treat conditions such as cardiac arrhythmias (e.g., atrial fibrillation), liver tumors, kidney tumors, and chronic pain management. This versatility makes RF technology a go-to choice for physicians dealing with various medical specialties. Moreover, RF ablation has a long history of safe and successful use in medical procedures. The technology has been refined over the years, and clinicians have extensive experience with its application. This track record of safety and efficacy instills confidence in both healthcare providers and patients.
Cancer treatment holds the largest market share
Cancer is a widespread and prevalent disease that affects millions of people globally. It can occur in various organs and tissues, leading to a high demand for effective treatment options. As the incidence of cancer continues to rise due to factors like aging populations and lifestyle changes, the need for cancer treatment methods, including ablation, remains significant. Moreover, ablation techniques have proven to be versatile in the field of oncology. These procedures can be used to treat both primary tumors and metastatic lesions, making them applicable across different stages and types of cancer. Ablation can be employed in various organs, such as the liver, kidney, lung, and bone, providing clinicians with a wide range of treatment options.
Hospitals accounts for majority of market share
Ablation procedures often require specialized equipment and trained medical professionals. Hospitals are well-equipped to handle complex medical interventions and have the necessary infrastructure, including operating rooms, imaging technology, and support staff, to perform these procedures safely and effectively. This makes hospitals the natural choice for patients seeking ablation treatments. Moreover, hospitals house a wide range of medical specialties, including cardiology, oncology, gastroenterology, urology, and more. Ablation devices are used across multiple medical disciplines to treat various conditions. Hospitals can offer a comprehensive suite of ablation services, making them a one-stop destination for patients with diverse medical needs.
North America exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. The region is home to world-renowned medical institutions, hospitals, and research centers. This advanced infrastructure provides a solid foundation for the adoption of cutting-edge medical technologies, including ablation devices. Moreover, the region has one of the highest healthcare expenditure rates in the world. This substantial investment in healthcare, both by governments and private entities, enables the procurement of state-of-the-art medical equipment, including ablation devices. It also supports research and development efforts in the healthcare sector, leading to innovation and product advancements.
The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are allocating significant resources to research and development efforts to develop innovative and technologically advanced ablation devices. This includes the development of next-generation ablation systems with enhanced precision, safety features, and user-friendly interfaces. They are also expanding their product portfolios to offer a comprehensive range of ablation devices catering to various medical specialties and applications. This includes devices designed for cardiac ablation, oncology, pain management, gynecology, and more. Moreover, companies are expanding their reach into new geographical markets. This expansion involves obtaining regulatory approvals and certifications in different regions, establishing distribution networks, and adapting their products to meet specific regional requirements.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: